<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04621981</url>
  </required_header>
  <id_info>
    <org_study_id>RIN005-R</org_study_id>
    <nct_id>NCT04621981</nct_id>
  </id_info>
  <brief_title>Sodium Bicarbonate Ringer's Solution Versus Normal Saline for Early Fluid Resuscitation in Patients With Sepsis</brief_title>
  <official_title>Sodium Bicarbonate Ringer's Solution Versus Normal Saline for Early Fluid Resuscitation in Patients With Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xiangya Hospital of Central South University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xiangya Hospital of Central South University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      At present, people still have different opinions on choosing which kind of crystalloid&#xD;
      solution for patients with sepsis, and there is no unified standard yet. It is necessary to&#xD;
      conduct systematic studies on comparison of different fluid resuscitation methods on the&#xD;
      efficacy and safety of crystalloid solution for patients with sepsis. Therefore, this study&#xD;
      focuses on the efficacy and safety of sodium bicarbonate Ringer's solution compared with&#xD;
      normal saline.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sepsis and septic shock are clinical emergencies requiring immediate treatment and fluid&#xD;
      resuscitation. Early effective fluid resuscitation can improve the prognosis of patients. So&#xD;
      far, there is no perfect crystalloid solution. Normal saline is the most readily available&#xD;
      and economical crystalline fluid for clinical resuscitation. It is isoosmotic and can meet&#xD;
      the basic needs of patients in the early rehydration. But it lacks acid-base buffer system&#xD;
      and potassium, calcium and magnesium ions, and the level of chloride ions is also&#xD;
      significantly higher than that of plasma.&#xD;
&#xD;
      Sodium Bicarbonate Ringer's solution contains physiological levels of Na+(130mmol/L),&#xD;
      K+(4mmol/L), Ca2+(1.5mmol/L), Mg2+(1mmol/L), HCO3-(28mmol/L) and Cl-(109mmol/L). It also has&#xD;
      citric acid/ sodium citrate buffer system (Citrate3-1.3mmol/L), pH7.3, and osmotic pressure&#xD;
      276mOsm/L. It is the most similar solution to extracellular fluid.&#xD;
&#xD;
      Theoretically，Compared with normal saline, Sodium Bicarbonate Ringer's solution can maintain&#xD;
      acid-base balance faster and better when restoring the microcirculation without affecting the&#xD;
      level of chloride ion. Therefore we hypothesize that Sodium Bicarbonate Ringer's solution can&#xD;
      promote the body to restore to acid-base balance more quickly, and improve organ function&#xD;
      more significantly than normal saline.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2020</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Sequential Organ Failure Assessment(SOFA) value at 24h</measure>
    <time_frame>0 hours, 24 hours</time_frame>
    <description>ΔSOFA=SOFA24h-SOFA0h</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum lactate clearance rate</measure>
    <time_frame>0 hours, 6 hours</time_frame>
    <description>(Serum lactete0h-serum lactate6h)/serum lactate0h</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The proportion of patients with serum lactate clearance rate&gt;30%</measure>
    <time_frame>0 hours, 6 hours, 24 hours</time_frame>
    <description>the proportion of patients whose serum lactate decrease by more than 30%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in pH value over time, and the lowest pH value during hospitalization</measure>
    <time_frame>0 hours, 3 hours, 6 hours, 24 hours</time_frame>
    <description>ΔpH=pH3h/6h/24h-pH0h, and the lowest pH value during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in base residue (BE value) over time</measure>
    <time_frame>0 hours, 3 hours, 6 hours, 24 hours</time_frame>
    <description>ΔBE=BE3h/6h/24h-BE0h</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in serum bicarbonate(HCO3-) over time</measure>
    <time_frame>0 hours, 3 hours, 6 hours, 24 hours</time_frame>
    <description>ΔHCO3-=HCO3-3h/6h/24h-HCO3-0h</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The proportion of patients with hyperchloremia</measure>
    <time_frame>0 hours, 3 hours, 24 hours</time_frame>
    <description>The proportion of patients with hyperchloremia at 3h and 24h.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in SOFA score over time</measure>
    <time_frame>0 hours, 24 hours, 48 hours, 72 hours</time_frame>
    <description>ΔSOFA=SOFA24h/48h/72h-SOFA0h</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in APACHEII score over time</measure>
    <time_frame>0 hours, 24 hours, 48 hours, 72 hours</time_frame>
    <description>ΔAPACHEII=APACHEII24h/48h/72h-APACHEII0h</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mechanical ventilation time(h)</measure>
    <time_frame>Within 7 days</time_frame>
    <description>the length of mechanical ventilation time within 7 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The proportion of patients receiving RRT</measure>
    <time_frame>Within 7 days</time_frame>
    <description>The proportion of patients receiving RRT within 7 days</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Sepsis, Septic Shock</condition>
  <arm_group>
    <arm_group_label>Sodium Bicarbonate Ringer's Solution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intravenous drip, 500~1000ml per time. Infusion speed: 15ml/kg/h or according to guidelines or department routine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous drip, 500~1000ml per time. Dosage depends on age、weight and symptoms.&#xD;
Infusion speed: According to the department process or clinician's decision.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Bicarbonate Ringer's Solution</intervention_name>
    <description>This group was treated with Sodium Bicarbonate Ringer's Solution.</description>
    <arm_group_label>Sodium Bicarbonate Ringer's Solution</arm_group_label>
    <other_name>Bicarbonated Ringer's solution</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal Saline</intervention_name>
    <description>This group was treated with normal saline.</description>
    <arm_group_label>Normal Saline</arm_group_label>
    <other_name>physiological saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosed as sepsis or septic shock according to the definition of Sepsis-3.0 with&#xD;
             fluid resuscitation requirement;&#xD;
&#xD;
          -  aged between 18 and 80, male or female;&#xD;
&#xD;
          -  Signed informed Consent (with delay within 24 hours).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with hypermagnesemia;&#xD;
&#xD;
          -  Patients with hypothyroidism;&#xD;
&#xD;
          -  Patients predicted to die or discharged within 24 hours after admission;&#xD;
&#xD;
          -  Patients with previous history of mental illness, severe hepatic and renal&#xD;
             insufficiency, severe cardiac disease, primary severe central nervous system lesions;&#xD;
&#xD;
          -  Pregnant or breast-feeding women;&#xD;
&#xD;
          -  Patients who have received cardiopulmonary resuscitation；&#xD;
&#xD;
          -  Patients who participated in other clinical trials within 30 days;&#xD;
&#xD;
          -  Patients have other conditions that are not appropriate for inclusion according to the&#xD;
             researcher's judgment.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lina Zhang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xiangya Hospital of Central South University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lina Zhang</last_name>
    <phone>+8615874875763</phone>
    <email>zln7095@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Lina Zhang</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>November 1, 2020</study_first_submitted>
  <study_first_submitted_qc>November 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2020</study_first_posted>
  <last_update_submitted>November 5, 2020</last_update_submitted>
  <last_update_submitted_qc>November 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fluid Resuscitation, Crystalloid Solution</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

